GGrantIndex
← Leaderboards

Bruce A Yankner

Children'S Hospital Boston

$46,152,835
Attributed
$51,974,155
Total exposure
16
Grants
14
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $4.5M · FY200525
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$59,670,786 · 17

By mechanism

R01$22,041,352 · 8
T32$18,010,753 · 1
P01$11,717,969 · 3
DP1$4,178,429 · 2
RF1$2,095,914 · 1
RC1$1,000,000 · 1

Top collaborators

Most similar at Children'S Hospital Boston

Same institution · by research overlap

Others in their field

Top investigators on “Alzheimer&Apos

Research focus

Alzheimer&AposBrainS DiseaseAgingGenesNerve DegenerationNeuronsInsightAging BrainPathologyBaseMediatingImpaired CognitionGene ExpressionMouse ModelMemoryGeneticLongevityStressSynaptic PlasticityGenomeAge RelatedInterdisciplinary ApproachPromotor (Genetics)

Grant awards (94)

Training in the Molecular Biology of Neurodegeneration and Alzheimer's Disease$1,004,633
T32 · FY2025 · AG · contact PI
Targeting REST in Alzheimer's Disease$883,942
R01 · FY2025 · AG · contact PI
Training in the Molecular Biology of Neurodegeneration and Alzheimer's Disease$945,105
T32 · FY2024 · AG · contact PI
Targeting REST in Alzheimer's Disease$901,982
R01 · FY2024 · AG · contact PI
Training in the Molecular Biology of Neurodegeneration and Alzheimer's Disease$962,829
T32 · FY2023 · AG · contact PI
Targeting REST in Alzheimer's Disease$901,982
R01 · FY2023 · AG · contact PI
Training in the Molecular Biology of Neurodegeneration and Alzheimer's Disease$939,920
T32 · FY2022 · AG · contact PI
Targeting REST in Alzheimer's Disease$901,345
R01 · FY2022 · AG · contact PI
Targeting REST in Alzheimer's Disease$916,686
R01 · FY2021 · AG · contact PI
Training in the Molecular Biology of Neurodegeneration and Alzheimer's Disease$889,813
T32 · FY2021 · AG · contact PI
Exploring a Novel Paradigm of Schizophrenia and Bipolar Disorder$936,323
R01 · FY2020 · MH · contact PI
Training in the Molecular Biology of Neurodegeneration and Alzheimer's Disease$877,047
T32 · FY2020 · AG · contact PI
REST and Neural Network Dysfunction in Alzheimer's Disease$626,369
R56 · FY2020 · AG · contact PI
Exploring a Novel Paradigm of Schizophrenia and Bipolar Disorder$936,323
R01 · FY2019 · MH · contact PI
Training in the Molecular Biology of Neurodegeneration and Alzheimer's Disease$841,813
T32 · FY2019 · AG · contact PI
Targeting a Novel Regulator of Brain Aging and Alzheimer's Disease$979,652
R01 · FY2018 · AG · contact PI
Exploring a Novel Paradigm of Schizophrenia and Bipolar Disorder$936,323
R01 · FY2018 · MH · contact PI
Training in the Molecular Biology of Neurodegeneration and Alzheimer's Disease$816,403
T32 · FY2018 · AG · contact PI
Targeting a Novel Regulator of Brain Aging and Alzheimer's Disease$978,427
R01 · FY2017 · AG · contact PI
Exploring a Novel Paradigm of Schizophrenia and Bipolar Disorder$940,706
R01 · FY2017 · MH · contact PI
Training in the Molecular Biology of Neurodegeneration and Alzheimer's Disease$796,164
T32 · FY2017 · AG · contact PI
Training in the Molecular Biology of Neurodegeneration$5,415
T32 · FY2017 · AG · contact PI
Targeting a Novel Regulator of Brain Aging and Alzheimer's Disease$976,136
R01 · FY2016 · AG · contact PI
Exploring a Novel Paradigm of Schizophrenia and Bipolar Disorder$940,706
R01 · FY2016 · MH · contact PI
Training in the Molecular Biology of Neurodegeneration$564,856
T32 · FY2016 · AG · contact PI
Targeting a Novel Regulator of Brain Aging and Alzheimer's Disease$872,459
R01 · FY2015 · AG · contact PI
Training in the Molecular Biology of Neurodegeneration$752,713
T32 · FY2015 · AG · contact PI
Targeting a Novel Regulator of Brain Aging and Alzheimer's Disease (ADMINISTRATIVE SUPPLEMENT- SAGE)$114,059
R01 · FY2015 · AG · contact PI
Genome Engineering an IPSC Model of Alzheimer's Disease$2,095,914
RF1 · FY2014 · AG · contact PI
Targeting a Novel Regulator of Brain Aging and Alzheimer's Disease$935,613
R01 · FY2014 · AG · contact PI
Modeling the Aging Epigenome$839,025
DP1 · FY2014 · AG · contact PI
Training in the Molecular Biology of Neurodegeneration$542,073
T32 · FY2014 · AG · contact PI
Modeling the Aging Epigenome$813,854
DP1 · FY2013 · AG · contact PI
Training in the Molecular Biology of Neurodegeneration$721,260
T32 · FY2013 · AG · contact PI
Modeling the Aging Epigenome$839,025
DP1 · FY2012 · AG · contact PI
Training in the Molecular Biology of Neurodegeneration$721,260
T32 · FY2012 · AG · contact PI
Modeling the Aging Epigenome$839,025
DP1 · FY2011 · OD · contact PI
TRAINING IN THE MOLECULAR BIOLOGY OF NEURODEGENERATION$469,521
T32 · FY2011 · AG · contact PI
DNA Damage and Neurodegeneration in the Aging Brain$1,521,156
P01 · FY2010 · AG · contact PI
Modeling the Aging Epigenome$847,500
DP1 · FY2010 · OD · contact PI
TRAINING IN THE MOLECULAR BIOLOGY OF NEURODEGENERATION$695,988
T32 · FY2010 · AG · contact PI
THE ROLE OF Cdk5 IN THE DNA DAMAGE RESPONCE DURING AGING AND NEURODEGENERATION$545,319
P01 · FY2010 · AG · contact PI
Epigenetic Analysis of iPS Cell Models of Aging and Alzheimer's Disease$500,000
RC1 · FY2010 · AG · contact PI
DNA DAMAGE AND NEURODEGENERATION IN THE AGING BRAIN$340,487
P01 · FY2010 · AG · contact PI
DNA Damage and Neurodegeneration in the Aging Brain$1,491,737
P01 · FY2009 · AG · contact PI
TRAINING IN THE MOLECULAR BIOLOGY OF NEURODEGENERATION$700,342
T32 · FY2009 · AG · contact PI
THE ROLE OF Cdk5 IN THE DNA DAMAGE RESPONCE DURING AGING AND NEURODEGENERATION$534,776
P01 · FY2009 · AG · contact PI
Epigenetic Analysis of iPS Cell Models of Aging and Alzheimer's Disease$500,000
RC1 · FY2009 · AG · contact PI
DNA DAMAGE AND NEURODEGENERATION IN THE AGING BRAIN$333,903
P01 · FY2009 · AG · contact PI
Gene Regulation and DNA Damage in the Aging Brain$322,879
R01 · FY2009 · AG · contact PI
Genomic Analysis of Human Aging and Cognitive Decline$313,453
R01 · FY2009 · AG · contact PI
DNA Damage and Neurodegeneration in the Aging Brain$248,111
P01 · FY2009 · AG · contact PI
DNA Damage and Neurodegeneration in the Aging Brain$99,949
P01 · FY2009 · AG · contact PI
DNA Damage and Neurodegeneration in the Aging Brain$1,448,317
P01 · FY2008 · AG · contact PI
TRAINING IN THE MOLECULAR BIOLOGY OF NEURODEGENERATION$695,534
T32 · FY2008 · AG · contact PI
THE ROLE OF Cdk5 IN THE DNA DAMAGE RESPONCE DURING AGING AND NEURODEGENERATION$519,208
P01 · FY2008 · AG · contact PI
DNA DAMAGE AND NEURODEGENERATION IN THE AGING BRAIN$324,186
P01 · FY2008 · AG · contact PI
Gene Regulation and DNA Damage in the Aging Brain$322,879
R01 · FY2008 · AG · contact PI
Genomic Analysis of Human Aging and Cognitive Decline$313,453
R01 · FY2008 · AG · contact PI
DNA Damage and Neurodegeneration in the Aging Brain$1,434,833
P01 · FY2007 · AG · contact PI
TRAINING IN THE MOLECULAR BIOLOGY OF NEURODEGENERATION$691,724
T32 · FY2007 · AG · contact PI
DNA DAMAGE AND NEURODEGENERATION IN THE AGING BRAIN$377,898
P01 · FY2007 · AG · contact PI
THE ROLE OF Cdk5 IN THE DNA DAMAGE RESPONCE DURING AGING AND NEURODEGENERATION$351,779
P01 · FY2007 · AG · contact PI
Studies on the Mechanism of Beta Amyloid Neurotoxicity$343,532
R01 · FY2007 · NS · contact PI
Genomic Analysis of Human Aging and Cognitive Decline$336,721
R01 · FY2007 · AG · contact PI
Gene Regulation and DNA Damage in the Aging Brain$329,469
R01 · FY2007 · AG · contact PI
DNA Damage and Neurodegeneration in the Aging Brain$1,452,528
P01 · FY2006 · AG · contact PI
Training in the Molecular Biology of Neurodegeneration$622,075
T32 · FY2006 · AG · contact PI
Genomic Analysis of Human Aging and Cognitive Decline$351,985
R01 · FY2006 · AG · contact PI
Studies on the Mechanism of Beta Amyloid Neurotoxicity$351,128
R01 · FY2006 · NS · contact PI
DNA DAMAGE AND NEURODEGENERATION IN THE AGING BRAIN$347,787
P01 · FY2006 · AG · contact PI
THE ROLE OF Cdk5 IN THE DNA DAMAGE RESPONCE DURING AGING AND NEURODEGENERATION$345,995
P01 · FY2006 · AG · contact PI
Gene Regulation and DNA Damage in the Aging Brain$339,308
R01 · FY2006 · AG · contact PI
Training in the Molecular Biology of Neurodegeneration$431,241
T32 · FY2005 · AG
Gene Regulation and DNA Damage in the Aging Brain$346,279
R01 · FY2005 · AG
Studies on the Mechanism of Beta Amyloid Neurotoxicity$343,956
R01 · FY2005 · NS
Training in the Molecular Biology of Neurodegeneration$679,603
T32 · FY2004 · AG
REGULATION OF AMYLOID BETA PROTEIN BY APOE &CHOLESTEROL$345,006
R01 · FY2004 · AG
Studies on the Mechanism of Beta Amyloid Neurotoxicity$344,067
R01 · FY2004 · NS
Training in the Molecular Biology of Neurodegeneration$660,158
T32 · FY2003 · AG
Studies on the Mechanism of Beta Amyloid Neurotoxicity$352,688
R01 · FY2003 · NS
REGULATION OF AMYLOID BETA PROTEIN BY APOE &CHOLESTEROL$334,955
R01 · FY2003 · AG
REGULATION OF THE APP/NOTCH GAMMA SECRETASE$275,340
R01 · FY2003 · AG
Training in the Molecular Biology of Neurodegeneration$625,607
T32 · FY2002 · AG
REGULATION OF AMYLOID BETA PROTEIN BY APOE &CHOLESTEROL$325,203
R01 · FY2002 · AG
REGULATION OF THE APP/NOTCH GAMMA SECRETASE$275,340
R01 · FY2002 · AG
TRAINING IN THE MOLECULAR BIOLOGY OF NEURODEGENERATION$357,656
T32 · FY2001 · AG
REGULATION OF AMYLOID BETA PROTEIN BY APOE &CHOLESTEROL$315,729
R01 · FY2001 · AG
REGULATION OF THE APP/NOTCH GAMMA SECRETASE$275,340
R01 · FY2001 · AG
MECHANISM OF BETA AMYLOID NEUROTOXICITY$252,716
R01 · FY2001 · NS
REGULATION OF AMYLOID BETA PROTEIN BY APOE &CHOLESTEROL$306,534
R01 · FY2000 · AG
REGULATION OF THE APP/NOTCH GAMMA SECRETASE$275,340
R01 · FY2000 · AG
MECHANISM OF BETA AMYLOID NEUROTOXICITY$245,388
R01 · FY2000 · NS
MECHANISM OF BETA AMYLOID NEUROTOXICITY$50,000
R01 · FY2000 · NS